Related Experiment Video
Updated: Aug 24, 2026

Growth Assays to Assess Polyglutamine Toxicity in Yeast
Published on: March 5, 2012
Clinical isolates of yeast produce a gliotoxin-like substance
1Department of Microbiology, Marshall University School of Medicine, Huntington, WV 25755-9430.
Abstract:
Candida infections are major causes of morbidity in compromised human hosts, but our understanding of the virulence of Candida remains incomplete. The possibility that toxic fungal metabolites belonging to the chemical class epipolythiodioxopiperzine (ETP), which are reported to possess immunomodulating and antiphagocytic properties may be produced by Candida species was investigated. Reversed phase HPLC analysis of flash evaporated chloroform extracts of 7 day cultures of clinical Candida isolates grown in Minimal Essential Medium (MEM) with 5% fetal calf serum revealed the presence of a compound which eluted at the same time as the ETP, gliotoxin. Of 50 strains of yeast tested, 32 produced this gliotoxin-like material. This material was tested for other properties of ETP type toxins including the presence of mercaptans (Ellman reaction), ultraviolet absorbance spectrum and antibacterial activity against Micrococcus lutea. These tests revealed gliotoxin-like material from yeast cultures to be similar to commercially supplied gliotoxin. This represents the first report of the presence of ETP-like compounds in yeast and raises the possibility that ETP's may contribute to the virulence of the organism.
Insights
This study found that Candida species can produce epipolythiodioxopiperzine (ETP)-like compounds, specifically gliotoxin. These toxins may contribute to Candida
Area of Science:
- Mycology
- Immunology
- Biochemistry
Background:
- Candida infections cause significant morbidity in immunocompromised individuals.
- The virulence factors of Candida species are not fully understood.
- Epipolythiodioxopiperzine (ETP) toxins have immunomodulating and antiphagocytic properties.
Purpose of the Study:
- To investigate the potential production of ETP toxins by Candida species.
- To determine if these ETP-like compounds contribute to Candida virulence.
Main Methods:
- Clinical Candida isolates were cultured and extracted.
- Reversed-phase High-Performance Liquid Chromatography (HPLC) was used to analyze extracts.
- The gliotoxin-like compound was tested for ETP-specific properties.
Main Results:
- 32 out of 50 Candida strains produced a gliotoxin-like compound.
- This compound exhibited properties similar to commercial gliotoxin, including mercaptan presence, UV absorbance, and antibacterial activity.
- This is the first report of ETP-like compounds in yeast.
Conclusions:
- Candida species can produce ETP-like compounds, including gliotoxin.
- These compounds may play a role in the virulence of Candida infections.
- Further research is needed to elucidate the exact contribution of ETPs to Candida pathogenesis.
Related Concept Videos
Yeast Signaling
Fungal Group Zygomycota
Bioreactor Controls-III
Production of Alcohol

